Local warehouses. Local dispatch. Australia · Canada · USA
Blend comparison

GLOW vs Wolverine.
Start with the components.

A side-by-side look at the listed blend amounts, shared components and specification questions for your enquiry.

The listed difference is the additional GHK component in GLOW. Aurelis lists GLOW as GHK 50 mg + BPC 10 mg + TB 10 mg, totalling 70 mg. Wolverine lists BPC 10 mg + TB 10 mg, totalling 20 mg. Both entries list the same amounts for the components abbreviated BPC and TB.

This comparison keeps the names as they appear in the shared catalogue. A blend name alone does not establish the full identity of its components, its liquid concentration or the specification of a finished kit. Use the table to prepare a precise enquiry rather than choosing by the largest total.

GLOW vs Wolverine at a glance

Aurelis listed blend components; amounts describe content, not a dose
CompareGLOWWolverine
Listed GHK component50 mgNot listed
Listed BPC component10 mg10 mg
Listed TB component10 mg10 mg
Sum of listed components70 mg20 mg
Full entryGLOW catalogue profileWolverine catalogue profile

The 50 mg difference comes from the additional listed GHK component. It does not mean GLOW contains more of the shared BPC or TB components. Keep all three component fields visible when comparing the blends, even when a short product title shows only the total.

Confirm what each abbreviation identifies

The source listing uses GHK, BPC and TB. Do not silently expand those labels into a different accepted specification. Ask for the full component identities and the basis of each listed amount for the offered material.

In particular, GHK should not automatically become GHK-Cu because another supplier uses that name for a similarly named blend. Our GHK vs GHK-Cu guide discusses that naming distinction. Likewise, ask what the BPC and TB abbreviations identify rather than treating a short label as complete identity documentation.

The separate BPC-157 vs TB-500 research comparison provides background on those named entries. It does not resolve the abbreviations in an offered blend or establish results for the blend itself.

Why the total does not rank the blends

70 mg and 20 mg are sums of different component lists. Comparing those totals alone discards the information that distinguishes the entries. A larger sum is not a measure of comparative effect, suitability or product quality.

Neither total specifies a liquid volume. It therefore cannot establish concentration or an amount delivered by a device. The content vs concentration guide explains how to keep mass, volume and concentration apart. Ask which reporting basis applies if an offered specification uses different units.

Compare the presentation separately

Include your preferred vial or pen-style kit format in the enquiry. Confirm the available presentation for the selected blend; an image elsewhere in the format collection is not a component list for every product.

For a kit enquiry, request the exact supplied configuration and the named material specification separately. For a vial enquiry, request the accepted content basis and unit count. Keep the material details intact if the presentation changes, and ask whether any component specification changes with it.

Keep other blends distinct

GLOW and Wolverine do not establish the composition of every blend with a related name. The blend guide keeps KLOW and the Ipamorelin + CJC no DAC listing marked as specification on request. Their unresolved details should stay unresolved until the actual component specification is supplied.

Use one line per selected blend in your enquiry. Record its catalogue name, listed component amounts, preferred format and requested quantity. Ask for matching identity and content records through our quality-documentation page, with any abbreviations clarified in writing.

Request the exact blend specification

Send your selected GLOW or Wolverine entry and destination in the USA, Canada or Australia. Request confirmation of current local availability, presentation and complete component identity. Keeping these details together makes the reply easier to compare with the catalogue.

Contact Aurelis Peptides or email sales@aurelispeptides.com. This page compares the existing listings; the enquiry should identify the exact specification offered for your order.

Connect with Aurelis

Your next enquiry
starts with the details.

Tell us the compound, listed content, preferred presentation and destination. Our team can discuss local availability and the documentation for your selected material.